2008年至2019年费用医疗保险中的处方药支出
Stacie B Dusetzina1,2, Haiden A Huskamp3, Xuanzi Qin1
1Department of Health Policy, Vanderbilt University School of Medicine, Nashville, Tennessee.
JAMA
|October 18, 2022
概括
连续注册的医疗保险收费受益者处方药支出从2008年的24%增加到2019年的27%. 这一增长包括零售 (D部分) 和临床医生 (B部分) 的药物,扣除了折扣.
科学领域:
- 健康经济学
- 制药政策
- 医疗保健支出
背景情况:
- 处方药的消费是公众和政策制定者的重要关注点.
- 之前的分析往往不包括临床医生使用的药物 (B部分),或仅集中在零售支出 (D部分).
- 关于医疗保险费用为服务群体中B部分和D部分药物支出的综合影响的数据有限.
研究的目的:
- 估计医疗保健总支出中处方药的比例.
- 分析零售 (D部分) 和临床医生 (B部分) 的处方药支出趋势.
- 为特定的医疗保险群体提供药物支出的综合评估.
主要方法:
- 使用20%的美国费用服务医疗保险受益人的随机样本进行了描述性,序列性,横截面分析.
- 该研究包括从2008年到2019年连续在A,B和D部分注册的受益人,不包括医疗保险优势注册人.
- 部分B和部分D药品的净支出被调整为通货膨胀和售后折扣,表达为人均医疗保健总支出的百分比.
主要成果:
- 持续注册的受益人人均医疗保健支出从2008年的16,345美元增加到2019年的20,117美元.
- 部分B的药物支出增加了一倍以上,从每人720美元增加到1641美元,而部分D的净支出则从3122美元增加到3477美元.
- 处方药 (B部分和D部分) 占年度医疗保健总支出的比例从2008年的24.0%上升到2019年的27.2%.
结论:
- 处方药约占2019年D部分注册的费用医疗保险受益人总医疗保健支出的27%.
- 即使考虑到售后折扣, 这一发现仍然很重要, 凸显了药品的巨大且不断增长的成本.
- 这项研究强调需要对医疗保险中的处方药支出进行持续监测和政策评估.
更多相关视频
相关概念视频
Prescription, Nonprescription and Orphan Drugs
830
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
830
Issues And Trends In Healthcare Delivery System
5.8K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.8K
Time Course of Drug Effect
2.2K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
2.2K
Drug Dosage Regimen: Overview
3.7K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.7K
Inhaled Medications
363
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
363
Drug Control Governance: Regulatory Bodies and Their Impact
229
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
229


